TELOID Trademark

Trademark Overview


On Friday, November 15, 2024, a trademark application was filed for TELOID with the United States Patent and Trademark Office. The USPTO has given the TELOID trademark a serial number of 98855334. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, November 15, 2024. This trademark is owned by GemVax & KAEL CO., LTD.. The TELOID trademark is filed in the Restaurant & Hotel Services category with the following description:

research and development of vaccines and medicine; medicine research; medical and pharmacological research services; scientific research services for medical purposes; development of pharmaceutical preparations and medicines; consultancy in analysis of biology sequence processing for medical research purposes; laboratory research in the field of pharmaceuticals; pharmaceutical drug development services; medical research laboratory services; scientific investigations for medical purposes; analysis and evaluation of medical product development; Drug discovery services; research on the subject of pharmaceuticals; medical laboratory services; development of biological preparations; research and development of amino acid for medical purpose; development of cell therapy products; laboratory research services relating to pharmaceuticals; scientific research for medical purposes in the field of cancerous diseases; clinical studies of medicines; scientific research in the field of pharmacy; pha...

General Information


Serial Number98855334
Word MarkTELOID
Filing DateFriday, November 15, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateFriday, November 15, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Servicesresearch and development of vaccines and medicine; medicine research; medical and pharmacological research services; scientific research services for medical purposes; development of pharmaceutical preparations and medicines; consultancy in analysis of biology sequence processing for medical research purposes; laboratory research in the field of pharmaceuticals; pharmaceutical drug development services; medical research laboratory services; scientific investigations for medical purposes; analysis and evaluation of medical product development; Drug discovery services; research on the subject of pharmaceuticals; medical laboratory services; development of biological preparations; research and development of amino acid for medical purpose; development of cell therapy products; laboratory research services relating to pharmaceuticals; scientific research for medical purposes in the field of cancerous diseases; clinical studies of medicines; scientific research in the field of pharmacy; pharmaceutical research and development; biotechnology research; biomedical research services; drug development; stem cell research services; pharmaceutical research services; consultancy in analysis of genomics for medical research purposes; basic and clinical research in the field of respiratory science and medicine; conducting early evaluations in the field of new pharmaceuticals; pharmaceutical products evaluation; scientific research for medical purposes in the area of cancerous diseases; research and development of peptide for medical purposes

Classification Information


International Class043 - Services for providing food and drink; temporary accommodations.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, November 15, 2024
Primary Code043
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGemVax & KAEL CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressDaejeon 34036
KR

Trademark Events


Event DateEvent Description
Friday, November 15, 2024NEW APPLICATION ENTERED
Friday, November 15, 2024APPLICATION FILING RECEIPT MAILED